Clinical Trial Update: Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes results from a supplemental open-label arm in a Phase 1/2 study exploring dopaminergic system involvement in mobility resi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinsonian Signs in Older Persons | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-04-14